NCT06193187View on ClinicalTrials.gov

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

March 31, 2024

Study Completion Date

August 31, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

Sacubitril and Valsartan Sodium Tablets 24 mg/26 mg

Test (T)

DRUG

Entresto 50 mg

Reference (R)

Trial Locations (1)

10700

Siriraj Institute of Clinical Research (SICRES), Bangkok

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories (Thailand) Limited

INDUSTRY